2022 Best In KLAS Oncology: Medical

When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Epic “complete look” provides a high-level analysis of the key products that make up Epic’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Evident , MEDITECH , and Oracle Health [Cerner] .)

When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Altera Digital Health (Allscripts) Sunrise “complete look” provides a high-level analysis of the key products that make up Altera Digital Health’s enterprise suite. (Other reports in the series do the same for Epic , Evident , MEDITECH , and Oracle Health [Cerner] .) This report focuses on the core Sunrise suite and its supporting technology; data on Altera Digital Health’s standalone ambulatory platforms (TouchWorks and Professional) is excluded.

Performance

Oncology 2023

06 June 23 | Monique Rasband and Spencer Corbett

The market for both medical and radiation oncology EMRs is shifting. For medical oncology, many previously independent oncology practices and cancer centers have been consolidated into larger health systems, leading to the adoption of medical oncology modules from acute care EMR vendors—a trend that is set to continue. Additionally, customer satisfaction in the radiation oncology market has shifted in recent years as the two primary vendors have competed for each other’s customers. Leveraging the perspectives of 158 organizations, this report explores the performance of medical and radiation oncology EMR vendors to see which are meeting customer needs and which are falling behind.

	Overall performance score (100-point scale)	Trend (2021-2022)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Epic Beacon	89.4	+3%	n=29	A-	A	B	A-	A-	A-

Ontada (McKesson) iKnowMed (Mostly Ambulatory)	83.7	+8%	n=15	C+	A-	B	B-	B+	B+

Flatiron OncoEMR (Mostly Ambulatory)	79.9	-4%	n=31	C+	B	B	B-	B	C+

Oracle Health Cerner PowerChart Oncology	77.8	+2%	n=23	C+	B	C	B-	C	C
	50.0	100.0

	Overall Performance Score (100-point scale)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Elekta MOSAIQ - Medical Oncology L	73.2	n=7	C-	C-	B-	C	B-	C

Varian (A Siemens Healthineers Company) ARIA - Medical Oncology L	77.5	n=11	B-	C	B-	C	B	B-

Oncology: Medical

Past Oncology: Medical Awards

Contact KLAS

Tell us about your organization

How can we help you?